United-Guardian (UG)
Develops specialty ingredients, pharmaceuticals, and medical lubricants through Guardian Laboratories.
Something off on this page? Send us feedback.
Develops and markets specialty cosmetic, personal-care, and sexual-wellness ingredients alongside pharmaceuticals and medical lubricants. Guardian Laboratories' Lubrajel and Renacidin lines account for nearly all sales, making those product families central to the business.
Through Guardian Laboratories, develops, manufactures, and markets specialty cosmetic, personal-care, and sexual-wellness ingredients, as well as healthcare products including pharmaceuticals and medical lubricants. Its R&D work develops new ingredients and refines or expands uses for existing products.
Lubrajel and Renacidin are the two central product lines, together accounting for nearly all sales. Product innovation is the company's stated operating focus, supported by a collaborative R&D environment and efforts to retain technical talent.
Operations are based in Hauppauge, New York. The business is structurally dependent on the continued performance of the Lubrajel and Renacidin product families.
Company facts
No analyst consensus on record.
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $8.9M · Total debt $0 · Total assets $13.6M · Shareholders' equity $11.6M
- Revenue
- $3.1M
- Operating income
- $754.1K
- Net income
- $728.6K
HistoryDividendAnnual yield
| Institutions | 19.24% | 884.1K shares | |
|---|---|---|---|
| 28 holders · as of Jun 30, 2026 | |||
| Insiders | 22.45% | 1.03M shares | |
| 1 holder · as of Jan 23, 2026 | |||
| Other | 58.31% | 2.68M shares | |
| remainder | |||
4.59M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
Kenneth H. GlobusInsiderdirector | 22.45% | 1.03M | filed Jan 23, 2026 |
Renaissance Technologies LLCInstitution | 3.63% | 166,766 | as of Jun 30, 2026 |
Gamco Investors, Inc. et alInstitution | 3.58% | 164,388 | as of Jun 30, 2026 |
Vanguard Capital Management LLCInstitution | 2.79% | 128,340 | as of Jun 30, 2026 |
Dimensional Fund Advisors LPInstitution | 1.59% | 73,170 | as of Jun 30, 2026 |
Insider tradesForm 4
No open-market trades in the last 12 months.
